Marshall Wace’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.14M | Sell |
|
|||||
|
2025
Q1 | $5.71M | Buy |
|
|||||
|
2024
Q4 | $3.99M | Sell |
|
|||||
|
2024
Q3 | $60.9M | Sell |
|
|||||
|
2024
Q2 | $171M | Buy |
|
|||||
|
2024
Q1 | $180M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $23.8M | Sell |
|
|||||
|
2023
Q2 | $89.7M | Sell |
|
|||||
|
2023
Q1 | $193M | Buy |
|
|||||
|
2022
Q4 | $191M | Buy |
|
|||||
|
2022
Q3 | $109M | Buy |
|
|||||
|
2022
Q2 | $72.8M | Buy |
|
|||||
|
2022
Q1 | $49.1M | Sell |
|
|||||
|
2021
Q4 | $171M | Buy |
|
|||||
|
2021
Q3 | $125M | Buy |
|
|||||
|
2021
Q2 | $105M | Sell |
|
|||||
|
2021
Q1 | $266M | Buy |
|
|||||
|
2020
Q4 | $213M | Buy |
|
|||||
|
2020
Q3 | $184M | Buy |
|
|||||
|
2020
Q2 | $15.9M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $30.8M | Buy |
|
|||||
|
2019
Q3 | $16M | Buy |
|
|||||
|
2019
Q2 | $9.9M | Buy |
|
|||||
|
2019
Q1 | $1.09M | Buy |
|
|||||
|
2018
Q4 | $461K | Sell |
|
|||||
|
2018
Q3 | $6.39M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $35.7M | Buy |
|
|||||
|
2016
Q3 | $3.37M | Sell |
|
|||||
|
2016
Q2 | $8.92M | Buy |
|
|||||
|
2016
Q1 | $4.29M | Buy |
|
|||||
|
2015
Q4 | $1.18M | Sell |
|
|||||
|
2015
Q3 | $2.13M | Sell |
|
|||||
|
2015
Q2 | $14M | Buy |
|